Drugs and biologicals
Ended Awarded
- Contract number
- HHSN26300232
- Awardee
-
Pierce Biotechnology Inc. UEI CCSJMTEVB1V7
- Awarding agency
-
Office of the Director
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,215
Award facts
- Contract value 50% obligated
-
- $5,215.20 Current, with exercised options
- $10,430.40 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325998 All Other Miscellaneous Chemical Product and Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Rockford, IL 61105, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract HHSN26300232?
HHSN26300232 was awarded to Pierce Biotechnology Inc. by Office of the Director (National Institutes of Health) on March 4, 2013.
How much is contract HHSN26300232 worth?
The government has obligated $5,215 on HHSN26300232. Its potential value, with all options, is $10,430.
Is contract HHSN26300232 an order under another contract?
Yes. HHSN26300232 is a BPA call under HHSN263199800049380B, a blanket purchase agreement.
Was contract HHSN26300232 competed?
The extent of competition for HHSN26300232 was competed under sap. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award